Neurofibromatosis Therapeutic Acceleration Program (NTAP) has created the Francis S. Collins Scholars Program in Neurofibromatosis Clinical and Translational Research, a program designed to build a community of exceptional clinician scientists who will lead neurofibromatosis type 1 (NF1) research and clinical care. Collins Scholars will receive essential support and resources that will enable them to focus their efforts on improving treatment options for NF1 patients.
The program will support clinician scientists in their last stages of post-doctoral training or in their first seven (7) years of faculty appointment, providing them with funding and resources that include:
- Full salary support
- Training in the care of NF1 patients
- Tuition support and formal training in clinical translational science
- Participation in collaborative translational research programs with government, academic and industry partners
- Stipends for research costs
- Travel costs for scientific meetings
- High level mentoring support
The program was launched in 2014, with first applications accepted in February, 2014 and successful recipients being announced in June, 2014. Additional scholarship application rounds will be announced each year. For further information about the program, please see Collins Scholar Application Guidelines and Instructions
About Francis S. Collins
The Scholars Program is named in honor of Dr. Francis S. Collins, who led the team that discovered the NF1 gene in 1990. In addition to this work, Dr. Collins has been at the forefront of advancing translational science in his roles as Director of the National Institutes of Health (NIH) and former Director of the National Human Genome Research Institute. His leadership helped to establish the National Center for Advancing Translational Sciences (NCATS) and Brain Research through Advancing Innovative Neurotechnologies (BRAIN).